Ocular's Axpaxli Cuts Risk Of Worsening In Late-Stage AMD Study

Ocular Therapeutix shares up on positive data for wet AMD treatment. Company focusing on retinal diseases and on track for FDA submission. Importance Rank: 1 read more

Go to News Site